semaglutide derived from FDA Warns on Certain Forms of Compounded PDB-101: Diabetes Mellitus: Diabetes Mellitus:

The 8 mg dose achieved 18.9% weight loss, and the 4 mg dose achieved 16.4% weight loss

doi: 10.1016/j.arcmed.2021.03.006 153 NasiriNMoiniAEftekhari-YazdiPKarimianLSalman-YazdiRArabipoorA

Further modification by replacing Ala 2 (by aminoisobutyric acid) and Phe 6 (by -methyl-phenylalanine derivative) led to the discovery of an 11-mer with potency that was only two to threefold lower than GLP-1

GIP : module linsuline, peut influencer le tissu adipeux et le mtabolisme nergtique

This is clinically proven. Only the brand-name versions have gone through clinical trials

The second criterion concerns health risk, and here the case is arguably stronger